Annual report pursuant to Section 13 and 15(d)

OPERATING BUSINESS SEGMENT AND INTERNATIONAL OPERATION INFORMATION

v3.20.4
OPERATING BUSINESS SEGMENT AND INTERNATIONAL OPERATION INFORMATION
12 Months Ended
Dec. 31, 2020
Segment Reporting [Abstract]  
OPERATING BUSINESS SEGMENT AND INTERNATIONAL OPERATION INFORMATION OPERATING BUSINESS SEGMENT AND INTERNATIONAL OPERATION INFORMATION
 
We have four business segments (Asia, Europe, North America, and Latin America and Other) based primarily upon the geographic region where each segment operates, as well as the internal organization of our officers and their responsibilities. Each of the geographic segments operate under the Nature’s Sunshine Products and Synergy® WorldWide brands. The Latin America and Other segment includes our wholesale business in which we sell products to various locally-managed entities, independent of the Company, that we have granted distribution rights for the relevant market.

Historically, our operating segments were based on brand, customer base, geographical operations with three operating business segments under the Nature’s Sunshine Products brand (NSP Americas; NSP Russia, Central and Eastern Europe; and NSP China), and one operating business segment under the Synergy® WorldWide brand.

Reportable business segment information for the years ended December 31, 2020 and 2019 is as follows (dollar amounts in thousands):
Year Ended December 31, 2020 2019
Net sales:    
Asia $ 138,717  $ 138,536 
Europe 77,688  62,523 
North America 145,481  138,163 
Latin America and Other 23,319  22,993 
Total net sales 385,205  362,215 
Contribution margin (1):    
Asia 66,801  65,871 
Europe 26,014  19,954 
North America 50,193  49,327 
Latin America and Other 9,771  9,713 
Total contribution margin 152,779  144,865 
Selling, general and administrative (2) 131,297  128,740 
Operating income 21,482  16,125 
Other income (loss), net 1,339  (483)
Income before provision for income taxes $ 22,821  $ 15,642 
___________________________
(1) Contribution margin consists of net sales less cost of sales and volume incentives expense.

(2)  Service fees in China totaled $11.7 million and $9.4 million for the years ended December 31, 2020 and 2019, respectively. These service fees are included in our selling, general and administrative expenses.
Year Ended December 31, 2020 2019
Capital expenditures:    
Asia $ 542  $ 3,262 
Europe 34  27 
North America 4,267  2,605 
Latin America and Other 62  21 
Total capital expenditures $ 4,905  $ 5,915 
Depreciation and amortization:    
Asia $ 1,919  $ 1,544 
Europe 77  75 
North America 8,673  8,855 
Latin America and Other 74  125 
Total depreciation and amortization $ 10,743  $ 10,599 

As of December 31, 2020 2019
Assets:    
Asia $ 82,572  $ 65,959 
Europe 16,398  15,187 
North America 142,324  124,337 
Latin America and Other 8,204  7,585 
Total assets $ 249,498  $ 213,068 
 
From an individual country perspective, only the United States and South Korea comprise approximately 10 percent or more of consolidated net sales for the years ended December 31, 2020 and 2019 as follows (dollar amounts in thousands):
Year Ended December 31, 2020 2019
Net sales:    
United States $ 134,976  $ 128,019 
South Korea 62,041  70,556 
Other 188,188  163,640 
Total net sales $ 385,205  $ 362,215 
Revenue generated by each of our product lines is set forth below (dollars in thousands):
Year Ended December 31, 2020 2019
Asia:    
General health $ 36,445  $ 37,795 
Immunity 847  940 
Cardiovascular 40,496  44,541 
Digestive 32,605  24,434 
Personal care 10,606  13,753 
Weight management 17,718  17,073 
  138,717  138,536 
Europe:    
General health $ 32,822  $ 22,469 
Immunity 8,231  5,130 
Cardiovascular 10,863  10,672 
Digestive 18,673  14,456 
Personal care 4,663  7,463 
Weight management 2,436  2,333 
  77,688  62,523 
North America:    
General health $ 61,897  $ 59,847 
Immunity 23,036  15,341 
Cardiovascular 15,852  18,750 
Digestive 32,851  33,077 
Personal care 7,587  6,170 
Weight management 4,258  4,978 
  145,481  138,163 
Latin America and Other:    
General health $ 6,867  $ 6,919 
Immunity 3,122  2,453 
Cardiovascular 1,512  1,446 
Digestive 9,863  10,258 
Personal care 1,203  1,056 
Weight management 752  861 
  23,319  22,993 
Total net sales $ 385,205  $ 362,215 
 
From an individual country perspective, only the United States comprise 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):
As of December 31  2020 2019
Property, plant and equipment    
United States $ 50,025  $ 54,470 
Other 4,330  5,042 
Total property, plant and equipment $ 54,355  $ 59,512